Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 27, 2017
[Analysis of Hematopoietic Reconstitution in Auto-Peripheral Blood Hematopoietic Stem Cell Transplantation]Ying-Ying Chen, Xiao-Li Zhao, Hong-Hua Li, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 6, 2007
[Salvage therapy with proteasome inhibitor bortezomib for relapsed and refractory multiple myeloma]Wen-Rong Huang, Rong Li, Yu Jing, et al.Biochemical and Biophysical Research Communications|March 21, 2015
SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signalingJun Xu, Hui-Yan Sun, Feng-Jun Xiao, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 17, 2020
[Clinical Significance of Serum Immunoglobulin Level after Peri- pheral Blood Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies]Tao Lin, Shu Fang, Fei-Yan Wang, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 22, 2010
[Comparative efficacy of PD and VAD regimens for multiple myeloma]Yu Zhao, Yu Jing, Jian Bo, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2016
[Effect of rhG-CSF Mobilization on S1P5 Expression in T Lymphocyte Subsets of Allo-HSCT Donors]Meng Li, Li-Xun Guan, Zhen-Yang Gu, et al.Annals of Hematology|June 24, 2020
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignanciesXiao-Ning Gao, Ji Lin, Li-Jun Wang, et al.Annals of Hematology|June 28, 2019
Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignanciesXiao-Ning Gao, Ji Lin, Li-Jun Wang, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 14, 2008
[Construction and identification of Kir2ds4 RNAi lentiviral vector]Li-Ping Dou, Wan-Ming DA, Chang Wang, et al.Annals of Hematology|February 13, 2019
Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemiaXiao-Ning Gao, Ji Lin, Li-Jun Wang, et al.Pageof 12